Literature DB >> 3947916

Familial hypocalciuric hypercalcaemia as a differential diagnosis of hyperparathyroidism: studies in a large kindred and a review of surgical experience in the condition.

T J Lyons, P F Crookes, W Postlethwaite, B Sheridan, R C Brown, A B Atkinson.   

Abstract

We have studied 46 members of a large kindred with familial hypocalciuric hypercalcaemia (FHH) after a neck exploration failed to cure hypercalcaemia in an asymptomatic patient. Serum calcium, serum phosphate, plasma parathormone and vitamin D metabolites do not distinguish affected members from patients with hyperparathyroidism. Because of the continuing debate as to whether or not FHH is a variant of, or distinct from, hyperparathyroidism, we have carried out a review of surgical experience with subtotal parathyroidectomy in hyperparathyroidism secondary to parathyroid hyperplasia and in FHH. Whereas the procedure is successful in 90 per cent of the former cases only one case of FHH has been cured by it. This provides evidence for the two conditions being aetiologically distinct. Before patients with asymptomatic hypercalcaemia are referred for parathyroid surgery the calcium:creatinine clearance ratio should be measured using a 2 h urine sample collected after an overnight fast and a fasting blood sample. If this ratio is less than 0.01 then screening of first degree relations should be undertaken before any parathyroid surgery is performed. Unnecessary surgery can therefore be avoided.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3947916     DOI: 10.1002/bjs.1800730310

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  2 in total

1.  Spondylometaphyseal dysplasia with hypercalcemia.

Authors:  A Bagga; R N Srivastava; S Gupta; A Gupta
Journal:  Pediatr Radiol       Date:  1989

2.  A novel mutation in the calcium-sensing receptor gene in an Irish pedigree showing familial hypocalciuric hypercalcemia: a case report.

Authors:  Wael F Elamin; Olivier de Buyl
Journal:  J Med Case Rep       Date:  2010-10-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.